ELEVEN BIOTHERAPEUTICS, INC.

Company

Carisma Therapeutics Inc.

Filed

November 8, 2017

Accession Number

0000902664-17-004237

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →